tiprankstipranks
Advertisement
Advertisement

GB:0MTD Stock Latest News

Sobi Calls 2026 AGM With In-Person and Postal Voting Options
Company AnnouncementsSobi Calls 2026 AGM With In-Person and Postal Voting Options
16d ago
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
PremiumThe Fly
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
2M ago
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
PremiumThe Fly
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
2M ago
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
PremiumThe Fly
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
2M ago
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
PremiumCompany Announcements
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
2M ago
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
PremiumThe FlySwedish Orphan upgraded to Outperform from Underperform at BNP Paribas
2M ago
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
Premium
Company Announcements
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
2M ago
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
2M ago
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
PremiumCompany Announcements
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
3M ago
PremiumCompany Announcements
Sobi Advances Gamifant After Positive Phase 2a Data in Interferon-Gamma–Driven Sepsis
3M ago
Swedish Orphan Biovitrum Ab Completes Key Study on Still’s Disease in Italy
PremiumCompany Announcements
Swedish Orphan Biovitrum Ab Completes Key Study on Still’s Disease in Italy
4M ago
0MTD
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
PremiumCompany Announcements
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
4M ago
Swedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
PremiumCompany AnnouncementsSwedish Orphan Biovitrum’s Phase 3 Study on Pacritinib: A Potential Game-Changer for Myelofibrosis Treatment
6M ago
0MTD
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
Premium
Company Announcements
Swedish Orphan Biovitrum’s PAXIS Study: A Potential Breakthrough for VEXAS Syndrome
6M ago
0MTD
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
Premium
Company Announcements
Swedish Orphan Biovitrum’s New Study on Hemophilia A Treatment: A Potential Game Changer?
6M ago
0MTD
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
PremiumCompany Announcements
Swedish Orphan Biovitrum Advances Haemophilia A Treatment with Ongoing Study
6M ago
0MTD
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
PremiumCompany Announcements
Swedish Orphan Biovitrum’s Promising Phase 4 Study on Haemophilia A Treatment
6M ago
0MTD
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
PremiumCompany Announcements
Swedish Orphan Biovitrum’s New Study on Still’s Disease: Market Implications and Insights
6M ago
0MTD
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
PremiumCompany Announcements
Swedish Orphan Biovitrum’s New Study on Anakinra: A Potential Game-Changer for FMF Treatment
6M ago
0MTD
IQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
PremiumCompany AnnouncementsIQVIA and Swedish Orphan Biovitrum’s PNH Study: A Potential Game-Changer for Pegcetacoplan
6M ago
IQV
Swedish Orphan Biovitrum’s Promising Study on Efanesoctocog Alfa for Haemophilia A
Premium
Company Announcements
Swedish Orphan Biovitrum’s Promising Study on Efanesoctocog Alfa for Haemophilia A
6M ago
0MTD
Swedish Orphan Biovitrum’s Nitisinone Study: A Closer Look at HT-1 Treatment Outcomes
Premium
Company Announcements
Swedish Orphan Biovitrum’s Nitisinone Study: A Closer Look at HT-1 Treatment Outcomes
6M ago
0MTD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >